Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders
NCT ID: NCT04618432
Last Updated: 2023-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
26 participants
OBSERVATIONAL
2020-11-03
2023-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It may be in the interest of the NIDCD Clinical Research Program (CRP) to collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders and to evaluate patients to determine candidacy for intramural clinical studies. This protocol will provide the administrative vehicle to enable the evaluation and provision of clinical care for patients with head and neck and communication disorders by the NIDCD CRP, Clinical Center, and consult services. No investigational therapies will be administered in this
study.
Objectives and Endpoints:
(Summation)To collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders
(Summation)To evaluate patients to determine candidacy for intramural clinical studies
Study Population:
Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers
Description of Sites:
NIH Clinical Center
Study Duration:
10 years
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Evaluation for Head and Neck Surgery Branch Studies
NCT00011492
Head and Neck Cancer Treatment Related Dysphagia
NCT02657850
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686
Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer
NCT00021424
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
NCT01627093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It may be in the interest of the NIDCD Clinical Research Program (CRP) to collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders and to evaluate patients to determine candidacy for intramural clinical studies. This protocol will provide the administrative vehicle to enable the evaluation and provision of clinical care for patients with head and neck and communication disorders by the NIDCD CRP, Clinical Center, and consult services. No investigational therapies will be administered in this
study.
Objectives and Endpoints:
(Summation)To collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders
(Summation)To evaluate patients to determine candidacy for intramural clinical studies
Study Population:
Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers
Description of Sites:
NIH Clinical Center
Study Duration:
10 years
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder.
* An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIH
* Patient or their Legally Authorized Representative is able to provide informed consent.
* Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clint T Allen, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute on Deafness and Other Communication Disorders (NIDCD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000077-DC
Identifier Type: -
Identifier Source: secondary_id
10000077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.